Pure Global

Study Intestinal Complaints During Chemotherapy. - Trial NCT05906186

Access comprehensive clinical trial information for NCT05906186 through Pure Global AI's free database. This phase not specified trial is sponsored by Spaarne Gasthuis and is currently Not yet recruiting. The study focuses on Constipation. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05906186
Not yet recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT05906186
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Study Intestinal Complaints During Chemotherapy.

Study Focus

Constipation

kiwifruit

Observational

behavioral

Sponsor & Location

Spaarne Gasthuis

Timeline & Enrollment

N/A

Sep 01, 2023

May 30, 2024

80 participants

Primary Outcome

1. How common are constipation symptoms in patients undergoing chemotherapy treatment?

Summary

Study intestinal complaints during chemotherapy. A prospective study into intestinal
 complaints in patients undergoing chemotherapy treatment. A pre and post implementation
 design is used to establish if eating two kiwi fruits per day can prevent constipation.

ICD-10 Classifications

Constipation
Irritable bowel syndrome with predominant constipation [IBS-C]
Other laxatives
Poisoning: Other laxatives
Other functional intestinal disorders

Data Source

ClinicalTrials.gov

NCT05906186

Non-Device Trial